RU2146706C1 - Моноклональное антитело, связывающееся с поверхностным антигеном вируса гепатита b, fab-фрагмент и способ снижения уровня циркулирующего поверхностного антигена вируса гепатита b у пациента - Google Patents
Моноклональное антитело, связывающееся с поверхностным антигеном вируса гепатита b, fab-фрагмент и способ снижения уровня циркулирующего поверхностного антигена вируса гепатита b у пациента Download PDFInfo
- Publication number
- RU2146706C1 RU2146706C1 RU95117092/13A RU95117092A RU2146706C1 RU 2146706 C1 RU2146706 C1 RU 2146706C1 RU 95117092/13 A RU95117092/13 A RU 95117092/13A RU 95117092 A RU95117092 A RU 95117092A RU 2146706 C1 RU2146706 C1 RU 2146706C1
- Authority
- RU
- Russia
- Prior art keywords
- hepatitis
- antibody
- virus
- hbsag
- patient
- Prior art date
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
- C07K16/082—Hepadnaviridae, e.g. hepatitis B virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
- C12N5/16—Animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
- G01N33/5761—Hepatitis B
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Hematology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- General Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Pathology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1992/009749 WO1994011495A1 (en) | 1992-11-06 | 1992-11-06 | Production of human monoclonal antibodies active against hepatitis b surface antigen |
Publications (2)
Publication Number | Publication Date |
---|---|
RU95117092A RU95117092A (ru) | 1997-03-27 |
RU2146706C1 true RU2146706C1 (ru) | 2000-03-20 |
Family
ID=22231529
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU95117092/13A RU2146706C1 (ru) | 1992-11-06 | 1992-11-06 | Моноклональное антитело, связывающееся с поверхностным антигеном вируса гепатита b, fab-фрагмент и способ снижения уровня циркулирующего поверхностного антигена вируса гепатита b у пациента |
Country Status (5)
Country | Link |
---|---|
JP (1) | JP2002502222A (de) |
KR (1) | KR100281163B1 (de) |
AT (1) | ATE207119T1 (de) |
DE (1) | DE69232140D1 (de) |
RU (1) | RU2146706C1 (de) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2766360C2 (ru) * | 2017-10-16 | 2022-03-15 | Ф. Хоффманн-Ля Рош Аг | МОЛЕКУЛЫ НУКЛЕИНОВЫХ КИСЛОТ ДЛЯ УМЕНЬШЕНИЯ УРОВНЯ мРНК PAPD5 ИЛИ PAPD7 ДЛЯ ЛЕЧЕНИЯ ИНФЕКЦИОННОГО ГЕПАТИТА В |
RU2784915C2 (ru) * | 2014-07-15 | 2022-12-01 | МЕДИММЬЮН, ЭлЭлСи | Нейтрализующие антитела к вирусу гриппа b и пути их применения |
US11534452B2 (en) | 2016-06-17 | 2022-12-27 | Hoffmann-La Roche Inc. | Nucleic acid molecules for reduction of PAPD5 or PAPD7 mRNA for treating hepatitis B infection |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117247944A (zh) | 2015-05-22 | 2023-12-19 | 华辉安健(北京)生物科技有限公司 | 抗前-s1 hbv抗体 |
JP7490574B2 (ja) * | 2018-05-31 | 2024-05-27 | ノバルティス アーゲー | B型肝炎抗体 |
-
1992
- 1992-11-06 JP JP51202994A patent/JP2002502222A/ja not_active Ceased
- 1992-11-06 DE DE69232140T patent/DE69232140D1/de not_active Expired - Lifetime
- 1992-11-06 AT AT93900518T patent/ATE207119T1/de not_active IP Right Cessation
- 1992-11-06 RU RU95117092/13A patent/RU2146706C1/ru not_active IP Right Cessation
- 1992-11-06 KR KR1019950701779A patent/KR100281163B1/ko not_active IP Right Cessation
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2784915C2 (ru) * | 2014-07-15 | 2022-12-01 | МЕДИММЬЮН, ЭлЭлСи | Нейтрализующие антитела к вирусу гриппа b и пути их применения |
US11534452B2 (en) | 2016-06-17 | 2022-12-27 | Hoffmann-La Roche Inc. | Nucleic acid molecules for reduction of PAPD5 or PAPD7 mRNA for treating hepatitis B infection |
RU2766360C2 (ru) * | 2017-10-16 | 2022-03-15 | Ф. Хоффманн-Ля Рош Аг | МОЛЕКУЛЫ НУКЛЕИНОВЫХ КИСЛОТ ДЛЯ УМЕНЬШЕНИЯ УРОВНЯ мРНК PAPD5 ИЛИ PAPD7 ДЛЯ ЛЕЧЕНИЯ ИНФЕКЦИОННОГО ГЕПАТИТА В |
US11484546B2 (en) | 2017-10-16 | 2022-11-01 | Hoffman-La Roche Inc. | Nucleic acid molecule for reduction of PAPD5 and PAPD7 mRNA for treating hepatitis B infection |
Also Published As
Publication number | Publication date |
---|---|
KR100281163B1 (ko) | 2001-04-02 |
DE69232140D1 (de) | 2001-11-22 |
KR950704478A (ko) | 1995-11-20 |
RU95117092A (ru) | 1997-03-27 |
ATE207119T1 (de) | 2001-11-15 |
JP2002502222A (ja) | 2002-01-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5648077A (en) | Treatment of patients infected with hepatitis B virus with a human monoclonal antibody | |
AU8506991A (en) | Homoconjugated immunoglobulins | |
JPS5929622A (ja) | モノクロ−ナル抗体、その製造法およびその用途 | |
JP2820402B2 (ja) | 補体成分C5aに対するモノクローナル抗体 | |
US5750106A (en) | Human monoclonal antibodies to cytomegalovirus | |
EP0158420B1 (de) | Monoklonale Antikörper gegen alpha-2 Interferon und Hybridomas, die solche Antikörper produzieren | |
EP0050129A1 (de) | Monoklonale antikörper. | |
RU2146706C1 (ru) | Моноклональное антитело, связывающееся с поверхностным антигеном вируса гепатита b, fab-фрагмент и способ снижения уровня циркулирующего поверхностного антигена вируса гепатита b у пациента | |
WO1988000472A1 (en) | Immunogens and improved methods of making immunogens | |
AU684455B2 (en) | Production of human monoclonal antibodies active against hepatitis B surface antigen | |
JP2565303B2 (ja) | 緑膿菌感染症の予防治療剤 | |
EP0672120B1 (de) | Die herstellung von menschlichen, monoklonalen antikörpern, die gegen das oberflächenantigen von hepatitis b aktiv sind | |
JP4880854B2 (ja) | 高い免疫反応性を有するタンパク質及びその製造方法 | |
AU662917B2 (en) | Antibodies to streptolysin O derivatives and variants | |
JPH08510635A (ja) | B型肝炎エスケープミュータント特異的結合分子 | |
EP0205352A2 (de) | Monoklonale antimenschliche IgG4-Antikörper, ihre Herstellung und Verwendung | |
WO1990004634A1 (en) | Monoclonal antibodies against receptor-induced binding sites | |
AU639671B2 (en) | Monoclonal antibodies against receptor-induced binding sites | |
JP2949291B2 (ja) | グラム陰性菌感染の処置および予防用組成物ならびに方法 | |
WO1994026784A1 (en) | Composition of antibodies against hepatitis b surface antigen | |
Kawasaki et al. | Serial study of phagocytic function in rat bovine serum albumin (BSA) nephritis. | |
RU2012594C1 (ru) | Штамм гибридных культивируемых клеток животных mus musculus l - продуцент моноклональных антител к 146s-компоненту вируса ящура азия-1 | |
JPH0441308B2 (de) | ||
JPS63253098A (ja) | ヒト抗体に対するモノクロ−ナル抗体、その製法及び用途 | |
JPH01290698A (ja) | 抗ストレプトリジンo モノクローナル抗体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20031107 |